StockNews.com initiated coverage on shares of Eagle Pharmaceuticals (NASDAQ:EGRX – Free Report) in a research report released on Wednesday. The brokerage issued a hold rating on the specialty pharmaceutical company’s stock.
Eagle Pharmaceuticals Price Performance
Shares of NASDAQ:EGRX opened at $1.16 on Wednesday. The firm has a 50 day moving average of $0.87 and a 200 day moving average of $1.60. Eagle Pharmaceuticals has a 52 week low of $0.00 and a 52 week high of $6.74.
Hedge Funds Weigh In On Eagle Pharmaceuticals
Several institutional investors and hedge funds have recently bought and sold shares of EGRX. Jacobs Levy Equity Management Inc. purchased a new position in Eagle Pharmaceuticals in the third quarter worth $453,000. Jane Street Group LLC purchased a new position in Eagle Pharmaceuticals in the third quarter worth $96,000. DGS Capital Management LLC grew its holdings in Eagle Pharmaceuticals by 44.9% in the third quarter. DGS Capital Management LLC now owns 71,728 shares of the specialty pharmaceutical company’s stock worth $268,000 after purchasing an additional 22,239 shares during the last quarter. Creative Planning purchased a new position in Eagle Pharmaceuticals in the third quarter worth $59,000. Finally, RBF Capital LLC grew its holdings in Eagle Pharmaceuticals by 11.7% in the third quarter. RBF Capital LLC now owns 143,078 shares of the specialty pharmaceutical company’s stock worth $534,000 after purchasing an additional 14,991 shares during the last quarter. 85.36% of the stock is owned by hedge funds and other institutional investors.
About Eagle Pharmaceuticals
Eagle Pharmaceuticals, Inc, a pharmaceutical company, focuses on developing and commercializing product candidates to treat diseases of the central nervous system or metabolic critical care, and oncology in the United States. The company offers Ryanodex for malignant hyperthermia; and Belrapzo and Bendeka for chronic lymphocytic leukemia and indolent B-cell non-Hodgkin’s lymphoma.
See Also
- Five stocks we like better than Eagle Pharmaceuticals
- How to Short a Stock in 5 Easy Steps
- Corporate Crawl: Where Business Trips Turn Into Party Nights
- Trading Stocks: RSI and Why it’s Useful
- CrowdStrike’s Growth Remains Strong—Buy While It’s Down
- 3 Home Improvement Stocks that Can Upgrade Your Portfolio
- Is Advanced Micro Devices Stock Slide Over?
Receive News & Ratings for Eagle Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Eagle Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.
